Back to Blogs

Nintedanib Supplier from India: A Guide for International Pharmaceutical Procurement

Category: Medicine
  • Tags:
  • Nintedanib, Nintedanib Capsules, Pharmaceutical Supplier India, Pharmaceutical Exporter India, Respiratory Medicines, Pharmaceutical Quality, Export Documentation, International Pharmaceutical Procurement
Blog post featured image

Introduction

Access to quality-assured medicines is an important consideration for hospitals, pharmaceutical distributors, healthcare institutions, and procurement organisations. For buyers sourcing specialist medicines, selecting a dependable supplier requires careful evaluation of product specifications, manufacturer credentials, quality documentation, regulatory requirements, and international shipping arrangements.

India has an established pharmaceutical industry serving domestic and international markets. For eligible pharmaceutical buyers, Indian suppliers may provide additional sourcing options for finished medicines, subject to product availability, manufacturer requirements, and the regulations of the destination country.

Dolphin Pharmaceuticals, based in Surat, Gujarat, India, offers pharmaceutical products across multiple therapeutic categories. Buyers looking for a nintedanib supplier from India can contact the company to enquire about potential sourcing options. The exact product, manufacturer, availability, supporting documentation, and export eligibility should be confirmed before placing an order.

This guide explains the main considerations involved in sourcing nintedanib capsules, from identifying the correct formulation to reviewing quality documents and coordinating international procurement.

Key Highlights

  • Generic name: Nintedanib.
  • Dosage form: Oral capsules; confirm the exact formulation offered.
  • Common strengths: 100 mg and 150 mg.
  • Therapeutic category: Kinase inhibitor.
  • Uses: Certain progressive fibrosing lung diseases and other approved indications, depending on the product label and destination market.
  • Potential buyers: Authorised pharmaceutical importers, distributors, hospitals, and eligible institutional procurement organisations.
  • Important procurement checks: Manufacturer identity, product specifications, batch documentation, shelf life, storage requirements, and regulatory status.
  • Supplier enquiry: Contact Dolphin Pharmaceuticals to confirm whether the requested product can be sourced for the intended market.

Product details and approved indications must be checked against the exact manufacturer's documentation. A supplier enquiry does not guarantee product availability or approval in any destination country.

Understanding Nintedanib Capsules

Nintedanib is a kinase inhibitor used in the management of certain fibrosing lung diseases. Depending on the applicable product approval, indications may include idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases with a progressive phenotype, and systemic sclerosis-associated interstitial lung disease.

The approved indications vary by jurisdiction and product label. Buyers should therefore confirm the exact product information applicable to the destination market rather than relying on a general description of the active ingredient.

Nintedanib is available in oral capsule formulations, including commonly referenced strengths of 100 mg and 150 mg. These strengths may be used differently according to the approved prescribing information and the treating specialist's assessment.

For pharmaceutical procurement teams, precise product identification is essential. Similar active ingredients do not remove the need to verify the strength, dosage form, manufacturer, packaging, and applicable authorisations.

Nintedanib is a prescription medicine. Treatment decisions, including product selection and dosage, must be made by qualified healthcare professionals.

Nintedanib Product Details for Buyers

When requesting a quotation, international buyers should establish the exact product specifications.

  • Generic name: Nintedanib.
  • Common strengths: 100 mg and 150 mg capsules.
  • Dosage form: Oral capsule; confirm the precise formulation.
  • Therapeutic category: Kinase inhibitor.
  • Approved uses: Depend on the specific product approval and destination market.
  • Route of administration: Oral.
  • Manufacturer: Confirm the legal manufacturer and manufacturing site.
  • Brand name: Specify a preferred brand, if applicable.
  • Packaging: Confirm available pack sizes and packaging configuration.
  • Storage: Follow the product-specific approved label. Some presentations require protection from moisture and storage within a controlled room-temperature range.
  • Shelf life: Confirm the expiry date and minimum remaining shelf life required by the importer.
  • Availability: Verify directly with the supplier.
  • Export eligibility: Confirm for the requested destination country before ordering.

These details provide a starting point for procurement discussions. They should not be interpreted as confirmation that Dolphin Pharmaceuticals currently stocks a specific nintedanib product.

Why Consider a Nintedanib Supplier from India?

International pharmaceutical buyers may evaluate suppliers in India as part of their sourcing strategy. However, a supplier should be selected on the basis of verifiable product information, appropriate documentation, regulatory compliance, and clear commercial terms.

1. Access to Pharmaceutical Sourcing Options

An Indian supplier may be able to review enquiries for different finished pharmaceutical products, depending on its portfolio and sourcing arrangements.

To help assess a nintedanib enquiry, buyers should provide the required strength, formulation, quantity, preferred manufacturer, packaging requirements, and destination country.

Clear specifications help reduce misunderstandings and make quotations easier to compare.

2. Manufacturer Transparency

The exporter and actual medicine manufacturer may be different entities. Buyers should establish whether the supplier manufactures the product directly or sources it from another pharmaceutical company.

Verify the manufacturer's legal name, manufacturing site where relevant, product label, and supporting documentation before approving an order.

3. Quality Documentation

Product quality is a central consideration when sourcing prescription medicines. Buyers should request documents relevant to the exact product and transaction.

Depending on the applicable requirements, these may include product specifications, batch details, a Certificate of Analysis, manufacturing information, and relevant quality certificates.

Documents should be checked for consistency with the product and batch being offered. Any discrepancy should be resolved before shipment.

4. International Procurement Coordination

International pharmaceutical procurement involves more than selecting a product. Buyers and suppliers need to coordinate quotations, payment terms, packaging, documentation, shipping arrangements, and regulatory responsibilities.

Clear written terms can help procurement teams plan budgets, manage internal approvals, and coordinate deliveries more effectively.

Dolphin Pharmaceuticals: Pharmaceutical Sourcing Enquiries

Dolphin Pharmaceuticals is based in Surat, Gujarat, India, and offers pharmaceutical products across multiple therapeutic categories.

For buyers searching for a nintedanib supplier from India, the company can be approached to discuss the specific sourcing requirement. Buyers should obtain confirmation of the exact product and proposed supply arrangement rather than assuming that every medicine is available.

Before proceeding, request confirmation of:

  • Nintedanib strength and formulation.
  • Brand name, where applicable.
  • Actual manufacturer and manufacturing site.
  • Current availability and quotation.
  • Packaging configuration and minimum order quantity, if applicable.
  • Relevant product and batch documentation.
  • Storage and transportation requirements.
  • Destination-country registration or approval status.
  • Export documentation and estimated lead time.

These checks help determine whether the proposed supply meets the buyer's procurement requirements.

How to Evaluate a Reliable Nintedanib Supplier

Selecting a pharmaceutical supplier requires a structured review of the product, supplier, and proposed transaction.

Verify Supplier Credentials

Review the supplier's business identity, relevant licences, and role in the pharmaceutical supply chain. Establish whether it is the manufacturer, an authorised distributor, or an exporter sourcing the medicine from another company.

Where required, verify the relevant authorisations for the manufacturer, exporter, and importing organisation.

Confirm Product Specifications

Ensure that the requested product is clearly identified by generic name, strength, dosage form, packaging, and manufacturer.

For nintedanib, distinguish between the 100 mg and 150 mg presentations and confirm that the proposed product matches the procurement specification.

Review Product and Batch Documentation

Request applicable product specifications and batch-related records. Confirm that the product name, strength, manufacturer, batch number, expiry information, and other relevant details are consistent across the documentation.

Do not approve a shipment until important discrepancies have been resolved.

Check Storage and Transportation Arrangements

Review the manufacturer's storage instructions and confirm that the proposed transport arrangements are appropriate for the exact product.

Some nintedanib capsule labels specify controlled room-temperature storage and protection from excessive heat and moisture. Requirements may differ between products, so the supplied product's approved label should take precedence.

Compare Complete Quotations

Compare supplier quotations using the same product specifications and commercial terms.

Consider the quoted price, minimum order quantity, packaging, remaining shelf life, payment terms, documentation, freight, insurance where applicable, and estimated delivery time.

A lower unit price alone is not sufficient evidence of product quality or supplier reliability.

Quality Documentation for Nintedanib Procurement

The documents required for nintedanib procurement depend on the product, manufacturer, transaction, and destination-market regulations.

Commercial Documents

Common commercial records may include:

  • Proforma invoice.
  • Commercial invoice.
  • Packing list.
  • Purchase order and agreed sales terms.
  • Applicable transport documentation.

Product and Quality Documents

Depending on the transaction, buyers may need:

  • Product specifications and product information.
  • Manufacturer and manufacturing-site details.
  • Batch number and expiry information.
  • Certificate of Analysis, where applicable.
  • Relevant manufacturing or quality certificates.
  • Product registration or approval records, where required.

Regulatory Documents

Importers should determine whether product registration, an import permit, importer authorisation, or additional regulatory documents are required.

The required documentation should be confirmed before shipment with the relevant authorities and supply-chain partners. Not every document applies to every product or destination.

Regulatory Compliance for International Pharmaceutical Supply

Pharmaceutical export and import activities are governed by the laws and procedures of the relevant countries. A medicine available from an Indian supplier is not automatically authorised for import or sale in another market.

Before confirming an order, buyers should establish:

  1. Whether the specific product is registered or otherwise authorised in the destination country.
  2. Whether an import permit or additional approval is required.
  3. Whether the importing organisation is authorised to receive and distribute the medicine.
  4. Which manufacturer, quality, and product documents must be submitted.
  5. Whether packaging and labelling meet local requirements.
  6. Whether special conditions apply to the product or proposed shipment.

Institutional procurement programmes may also have their own quality-assurance criteria or approved supplier requirements. Buyers should verify whether these apply to their transaction.

Regulatory checks should take place before the order is finalised or the medicine is dispatched.

Storage, Packaging, and Shipment Planning

Proper storage and transport are important parts of pharmaceutical supply management.

Storage Conditions

Follow the approved storage instructions for the exact nintedanib product. Some capsule products specify controlled room-temperature storage and protection from high humidity and excessive heat.

Do not assume that every brand or formulation has identical requirements.

Packaging and Labelling

Confirm the available pack size and ensure that the product packaging and labelling comply with the destination market's requirements.

Product identity, batch information, expiry details, and packaging integrity should be checked as part of the receiving process.

Shelf-Life Management

Ask for the proposed batch's expiry date and confirm that the remaining shelf life meets the importer's requirements.

International transit, customs clearance, and local distribution should be considered when planning the order.

Shipping Coordination

Agree on the shipping method, estimated dispatch date, transit time, documentation responsibilities, and any special handling conditions before dispatch.

The supplier, importer, and logistics provider should coordinate to ensure that the shipment is handled according to the product's documented requirements.

How to Request a Quotation from Dolphin Pharmaceuticals

A clear enquiry helps the supplier evaluate the request and determine whether an appropriate sourcing option may be available.

International buyers should provide:

  • Required nintedanib strength.
  • Preferred brand or manufacturer, if applicable.
  • Dosage form and pack size.
  • Required quantity.
  • Destination country.
  • Relevant registration or import requirements.
  • Documentation requirements.
  • Preferred delivery schedule.

Buyers should request written confirmation of the product details, actual manufacturer, availability, commercial terms, and export eligibility.

The quotation should clearly identify the product being offered so that it can be checked against the buyer's procurement specification.

Frequently Asked Questions

1. What is nintedanib used for?

Nintedanib is used for certain fibrosing lung diseases, including idiopathic pulmonary fibrosis and other indications specified in the applicable product approval. The approved uses may vary by jurisdiction and product.

2. What strengths of nintedanib are commonly available?

Commonly referenced capsule strengths include 100 mg and 150 mg. Buyers should verify the exact formulation and strength required.

3. Can I source nintedanib from India for international supply?

Potentially, subject to product availability, supplier and manufacturer authorisations, export requirements, and the destination country's regulations. All details should be confirmed before ordering.

4. Does Dolphin Pharmaceuticals currently stock nintedanib?

Current stock and sourcing availability must be confirmed directly with Dolphin Pharmaceuticals. Buyers should provide the required strength, quantity, preferred manufacturer, and destination country.

5. What documents should I request from a supplier?

Depending on the product and destination, relevant documents may include product specifications, manufacturer details, batch information, a Certificate of Analysis where applicable, quality certificates, and required registration or import documents.

6. How should nintedanib capsules be stored?

Follow the storage instructions on the approved label for the exact product supplied. Some presentations require controlled room-temperature storage and protection from excessive heat and moisture.

7. Can nintedanib be exported to every country?

No. Product registration, import permissions, and importer authorisation vary by destination. Buyers should verify the applicable requirements before confirming an order.

Conclusion

Finding a dependable nintedanib supplier from India requires careful evaluation of product specifications, manufacturer credentials, quality documentation, regulatory compliance, and international shipping arrangements.

Dolphin Pharmaceuticals, based in Surat, Gujarat, India, can be contacted to discuss potential sourcing requirements for nintedanib capsules. Buyers should confirm the exact strength, formulation, manufacturer, current availability, supporting documents, commercial terms, and destination-market eligibility before finalising an order.

For pharmaceutical importers, distributors, and institutional procurement teams, a clear product specification and a documented supplier review can help establish a more transparent and organised procurement process.

Planning a nintedanib procurement enquiry? Prepare the required strength, quantity, preferred manufacturer, destination country, and documentation requirements so that Dolphin Pharmaceuticals can assess the request and clarify potential next steps.

Disclaimer: This article is intended for pharmaceutical procurement and general informational purposes only. Nintedanib is a prescription medicine. Treatment decisions must be made by qualified healthcare professionals, and products should be sourced and distributed through authorised pharmaceutical channels.

My Company Name - Dolphin Pharmaceuticals

My Website - https://www.dolphinpharma.in/